Tectonic Therapeutic, Inc. — Director's Dealing 2019

Jan 18, 2019

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: AVROBIO, Inc. (AVRO)
CIK: 0001681087
Period of Report: 2019-01-16

Reporting Person: SVLSF VI, LLC (10% Owner)
Reporting Person: SV Life Sciences Fund VI, L.P. (10% Owner)
Reporting Person: SV Life Sciences Fund VI Strategic Partners, L.P. (10% Owner)
Reporting Person: SV Life Sciences Fund VI (GP), L.P. (10% Owner)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2019-01-16	Common Stock	J	778663	$0.00	Disposed	1866791	Indirect
2019-01-16	Common Stock	J	26660	$0.00	Disposed	63913	Indirect

Footnotes

F1: SV Life Sciences Fund VI, L.P. ("SV Life LP") distributed the shares to its limited partners on a pro rata basis.

F2: The shares are held directly by SV Life LP. SV Life Sciences Fund VI (GP), L.P. ("SV Fund VI GP") is the general partner of SV Life LP. The general partner of SV Fund VI GP is SVLSF VI, LLC. Each of SV Fund VI GP and SVLSF VI, LLC disclaims beneficial ownership of the shares owned directly by SV Life LP, except to the extent of any pecuniary interest therein.

F3: SV Life Sciences Fund VI Strategic Partners, L.P. ("SV Life SP LP") distributed the shares to its limited partners on a pro rata basis.

F4: The shares are held directly by SV Life SP LP. SV Fund VI GP is the general partner of SV Life SP LP. The general partner of SV Fund VI GP is SVLSF VI, LLC. Each of SV Fund VI GP, and SVLSF VI, LLC disclaims beneficial ownership of the shares owned directly by SV Life SP LP, except to the extent of any pecuniary interest therein.